Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis. | Mol Med Rep | 2021 | 33786612 | PubTator, text mining | PubMed |
| Integration of mechanical and ECM microenvironment signals in the determination of cancer stem cell states. | Curr Stem Cell Rep | 2021 | 33777660 | PubTator, text mining | PubMed |
| Role of FAT1 in health and disease. | Oncol Lett | 2021 | 33777221 | PubTator, text mining | PubMed |
| Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population. | Asian Pac J Cancer Prev | 2021 | 33773564 | PubTator, text mining | PubMed |
| Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. | NPJ Breast Cancer | 2021 | 33772032 | PubTator, text mining | PubMed |
| NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression. | Front Oncol | 2021 | 33767993 | PubTator, text mining | PubMed |
| Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis. | Mol Ther Nucleic Acids | 2021 | 33767919 | PubTator, text mining | PubMed |
| WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma. | Genes Dev | 2021 | 33766984 | PubTator, text mining | PubMed |
| MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation. | Front Oncol | 2021 | 33763375 | PubTator, text mining | PubMed |
| MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker. | Mol Med Rep | 2021 | 33760220 | PubTator, text mining | PubMed |
| The therapeutic implications of the genomic analysis of malignant pleural mesothelioma. | Nat Commun | 2021 | 33753750 | PubTator, text mining | PubMed |
| Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. | Nat Commun | 2021 | 33741915 | PubTator, text mining | PubMed |
| Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. | Cancer Lett | 2021 | 33737002 | PubTator, text mining | PubMed |
| Small extracellular vesicles with LncRNA H19 "overload": YAP Regulation as a Tendon Repair Therapeutic Tactic. | iScience | 2021 | 33733065 | PubTator, text mining | PubMed |
| Curcumol inhibits the viability and invasion of colorectal cancer cells via miR-30a-5p and Hippo signaling pathway. | Oncol Lett | 2021 | 33732375 | PubTator, text mining | PubMed |
| YAP promotes autophagy and progression of gliomas via upregulating HMGB1. | J Exp Clin Cancer Res | 2021 | 33726796 | PubTator, text mining | PubMed |
| Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway. | Front Pharmacol | 2021 | 33716735 | PubTator, text mining | PubMed |
| The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review. | Breast Care (Basel) | 2021 | 33716627 | PubTator, text mining | PubMed |
| Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category. | J Clin Exp Hematop | 2021 | 33716242 | PubTator, text mining | PubMed |
| Autophagy, an accomplice or antagonist of drug resistance in HCC? | Cell Death Dis | 2021 | 33712559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=64